Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.

about

Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.

Item

http://www.wikidata.org/entity/Q38280824

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Flexible selection of a single ...... a phase II/III clinical trial.

@en

type

Item

label

Flexible selection of a single ...... a phase II/III clinical trial.

@en

prefLabel

Flexible selection of a single ...... a phase II/III clinical trial.

@en

P1476

Flexible selection of a single ...... a phase II/III clinical trial.

@en

P2093

Susan Todd

http://www.w3.org/2001/XMLSchema#string

P2860

Galantamine for Alzheimer's disease and mild cognitive impairment

Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications

Testing and estimation in flexible group sequential designs with adaptive treatment selection.

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.

Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look.

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.

Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.

Sequential designs for phase III clinical trials incorporating treatment selection.

A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information.

Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.

P304

3104-3115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SIM.6567

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26112909

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

phase III clinical trial

P932

4745001

http://www.w3.org/2001/XMLSchema#string